ConductScience.org, home

Paper5327367

Mechanism of action of nalidixic acid on Escherichia coli. 3. Conditions required for lethality.

Deitz WH and 2 others. J Bacteriol, 1966. Cited by 139 papers, by iCite.

Cite this record

ConductScience Library. Mechanism of action of nalidixic acid on Escherichia coli. 3. Conditions required for lethality. Papers, record 5327367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5327367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanism of action of nalidixic acid on Escherichia coli. 3. Conditions required for lethality.
PubMed
Journal
J Bacteriol
PubMed
Year
1966
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
139
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Deitz WHW H
2Cook TMT M
3Goss WAW A

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Escherichia coliMajor topic
Nalidixic AcidMajor topic
Antimetabolites
Bacterial Proteins
Carbon Isotopes
Chloramphenicol
DNA, Bacterial
Dinitrophenols
In Vitro Techniques
RNA, Bacterial
Thymidine

Source PubMed

Download CSV of topics

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
214240940PHYSIOLOGICAL STATE OF ESCHERICHIA COLI AND THE INHIBITION OF DEOXYRIBONUCLEIC ACID SYNTHESIS BY PHENETHYL ALCOHOL.J Bacteriol1964https://conductscience.org/library/papers/14240940PubMed
313786618Resistance and cross-resistance of Escherichia coli mutants to anticancer agents: nitrogen mustard and nitromin.Radiat Res1961https://conductscience.org/library/papers/13786618PubMed
414219026MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI.J Bacteriol1964https://conductscience.org/library/papers/14219026PubMed
514276097MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLI.II. INHIBITION OF DEOXYRIBONUCLEIC ACID SYNTHESIS.J Bacteriol1965https://conductscience.org/library/papers/14276097PubMed
614450180Chloramphenicol-sensitive and-insensitive phases of the lethal action of streptomycin.J Bacteriol1962https://conductscience.org/library/papers/14450180PubMed
713727577Involvement of newly-formed protein in the syntheses of deoxyibonucleic acid.Biochim Biophys Acta1960https://conductscience.org/library/papers/13727577PubMed
813714314A study of radiosensitive and radioresistant mutants of Escherichia coli strain B.J Gen Microbiol1961https://conductscience.org/library/papers/13714314PubMed
1013764647Thymine deficiency and the normal DNA replication cycle. I.J Mol Biol1961https://conductscience.org/library/papers/13764647PubMed
1113792909The relationship between growth and survival after irradiation of Escherichia coli strain B and two resistant mutants.J Gen Microbiol1960https://conductscience.org/library/papers/13792909PubMed

Download CSV of references

Cited by64

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.

PMIDTitleJournalYearIn PapersSource
39859179Relative Distribution of DnaA and DNA in Escherichia coli Cells as a Factor of Their Phenotypic Variability.Int J Mol Sci2025https://conductscience.org/library/papers/39859179PubMed
33271787Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.Molecules2020https://conductscience.org/library/papers/33271787PubMed
31534779DNA double-strand break formation and repair as targets for novel antibiotic combination chemotherapy.Future Sci OA2019https://conductscience.org/library/papers/31534779PubMed
29642475Our Evolving Understanding of the Mechanism of Quinolones.Antibiotics (Basel)2018https://conductscience.org/library/papers/29642475PubMed
28119681Absence of tmRNA Has a Protective Effect against Fluoroquinolones in Streptococcus pneumoniae.Front Microbiol2016https://conductscience.org/library/papers/28119681PubMed
27142337Development of Persister-FACSeq: a method to massively parallelize quantification of persister physiology and its heterogeneity.Sci Rep2016https://conductscience.org/library/papers/27142337PubMed
26100898Antibiotic efficacy is linked to bacterial cellular respiration.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26100898PubMed
21897862A toxin-antitoxin module in Bacillus subtilis can both mitigate and amplify effects of lethal stress.PLoS One2011https://conductscience.org/library/papers/21897862PubMed
20855738Effect of N-1/c-8 ring fusion and C-7 ring structure on fluoroquinolone lethality.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20855738PubMed
19223646Contribution of oxidative damage to antimicrobial lethality.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19223646PubMed
18539731The epsilon subunit of DNA polymerase III Is involved in the nalidixic acid-induced SOS response in Escherichia coli.J Bacteriol2008https://conductscience.org/library/papers/18539731PubMed
17151069RecA can stimulate the relaxation activity of topoisomerase I: Molecular basis of topoisomerase-mediated genome-wide transcriptional responses in Escherichia coli.Nucleic Acids Res2007https://conductscience.org/library/papers/17151069PubMed
17043118Effect of anaerobic growth on quinolone lethality with Escherichia coli.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17043118PubMed
16559090Nalidixic Acid and the Metabolism of Escherichia coli.J Bacteriol1970https://conductscience.org/library/papers/16559090PubMed
16377712Lethal action of quinolones against a temperature-sensitive dnaB replication mutant of Escherichia coli.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16377712PubMed
15855526Lethality of quinolones against Mycobacterium smegmatis in the presence or absence of chloramphenicol.Antimicrob Agents Chemother2005https://conductscience.org/library/papers/15855526PubMed
10898691Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis.Antimicrob Agents Chemother2000https://conductscience.org/library/papers/10898691PubMed
9593120Modulation of gyrase-mediated DNA cleavage and cell killing by ATP.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9593120PubMed
9559820Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones.Antimicrob Agents Chemother1998https://conductscience.org/library/papers/9559820PubMed
9391140DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9391140PubMed

See all 64 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5327367

GET https://conductscience.org/api/papers/v1/5327367/cited_by?page=2